AI Summary

An updated review finds that evidence supporting cannabidiol (CBD) as an effective treatment for alcohol use disorder (AUD) is still lacking, indicating that further research is needed. The review notes that expanding pharmacological options for AUD is a priority because existing FDA‑approved medications show only modest benefits. It describes how CBD may affect neurotransmitter systems that regulate emotion and executive function, as well as the rewarding effects of alcohol, and could influence gut‑immune‑neural interactions relevant to AUD.

AI summaries can be wrong sometimes—always verify important details using the source article.